Please login to the form below
Alcon
This page shows the latest Alcon news and features for those working in and with pharma, biotech and healthcare.
Takeda sells blockbuster-in-waiting Xiirda to Novartis for $5.3bn
eye care division Alcon earlier this year.
Latest news
-
Alcon spun off, leaner Novartis raises profit forecast
The Switzerland-headquartered firm has just spun off its eye care division Alcon, raising $4.7bn in the process, and helping it to create a leaner firm focused on medicines, and ... Novartis is off to a strong start in 2019 with the Mayzent launch,
-
Francis exits Sandoz, reigniting spinoff rumours
Novartis already have the spin-off of its eyecare division Alcon in the pipeline, with the business unit to be divested in the first half of this year.
-
Novartis aims for 10 blockbuster launches by 2020
The company also announced cuts to its manufacturing operations, and confirmed the spin off of eyecare division Alcon, which could raise as much as $35bn this year.
-
Novartis sells off part of Sandoz portfolio
from its eye-division Alcon, which it acquired back in 2010.
-
GSK: we won’t be splitting up any time soon
The decision is in contrast to firms such as Novartis (selling its eyecare divison Alcon) and Lilly, which just announced the spin-off its animal health division Elanco.
More from news
Approximately 17 fully matching, plus 52 partially matching documents found.
Latest Intelligence
-
Deal Watch November 2016
To date it seems Sanofi is also considering a move. Meanwhile Novartis is reportedly considering a sale of its contact lens business which is part of the Alcon eye care division.
-
Pharma deals during April 2014
Remaining revenues will come from pharmaceuticals, eye care (Alcon) and generics (Sandoz) and of course its stake in GSK Consumer Health.
-
Healthcare industry apps
Developed by Alcon (a Novartis company) this comprehensive tool is designed to teach doctors how to make diagnoses using an ophthalmoscope.
-
Interview: Joseph Jimenez, Novartis
Our new eye-care business Alcon is also driving our growth, with net sales increasing six per cent in Q2.". ... Alcon is already delivering solid sales growth, with sales up six per cent on a proforma basis in the second quarter.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Agios appoints Celgene’s Jackie Fouse
Prior to her tenure at Celgene, Fouse worked for Alcon Laboratories, an ophthalmic pharmaceutical and medical device company.
-
Celgene’s president and COO to retire
Previously, Dr Fouse was chief financial officer of agribusiness and food company Bunge, and also brought executive leadership expertise from Alcon Laboratories and Nestlé.
-
Dr Robert Kim joins Apellis as chief medical officer
Meanwhile, at he served at GSK as VP of clinical ophthalmology, helping build its early stage clinical pipeline, and was VP and head of pharmaceutical product development at Novartis/Alcon.
-
Novartis makes trio of appointments to senior leadership team
Ball has been appointed as the new division head and chief executive officer of Alcon, replacing Jeff George, and is set to focus on its surgical and vision care division. ... Joseph Jimenez, chief executive officer of Novartis, said: “His expertise in
-
Novaliq GmbH appoints Friedrich von Bolen as chairman
Prior to his appointment as a board member of Novaliq, Dr Cagle was senior vice president of Alcon R&D and chief scientific officer from 1996 to mid-2008 having worked ... as a member of Alcon's research and development team for over thirty years.
More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Random42 Scientific Communication
Abbott. Abbvie. Advanced Bionics. Abivax. Alcon. Alkermes. Alnylam. Allergan. Amgen. Anika Therapeutics. ... Everyone is very impressed!". - Global Product Manager, Alcon. "This MOA sets a new bar for such work.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Rising demand and understaffing puts NHS waiting times up again
- Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects
- Bluebird puts €1.57m price on gene therapy Zynteglo
- Q&A with Raman Sehgal
- Hansoh Pharma shares head skyward after HKEX debut
- GSK joins forces with Doudna’s CRISPR lab
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- What are you doing, Dave?
- Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
- Fake News is Bad for your Health
- Ill informed patients make poor health decisions...
- Secrets of Pharma Advertising
- If the goal of branding is to be different, why do so many Pharma brand ads look the same?...
Quick links
Infographics
